Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Empagliflozin 25 mg Film-Coated Tablets vs JARDIANCE in Healthy Thai Volunteers Under Fasting Conditions
TCTR20250611005Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of empagliflozin (2 arms), sponsored by Bio-innova. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
empagliflozin
Beyond the preview
Go deeper on TCTR20250611005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250611005.